Announcements Trials
Browse Landscape

Status

Unknown 1Completed 1

Sponsor Class

OTHER 22OTHER_GOV 2INDUSTRY 1FED 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic adenoma 1Pancreatic Neoplasms 1Pancreatic Cyst 1Lymphadenopathy 1Cysts 1Arachnodactyly 1Adenoma, Islet Cell 1

Interventions

Paclitaxel 489Carboplatin 435Gemcitabine 394Docetaxel 385Cisplatin 359pembrolizumab 343Bevacizumab 335Nivolumab 261Pemetrexed 242Capecitabine 221Dexamethasone 213Fluorouracil 211Rituximab 203Trastuzumab 193Cyclophosphamide 190Oxaliplatin 160Erlotinib Hydrochloride 147Ipilimumab 145atezolizumab 144Prednisone 144Cetuximab 142Irinotecan 139Leucovorin 130Doxorubicin 130Sorafenib 120Lenalidomide 119Bortezomib 118Sunitinib 107Everolimus 93130-nm albumin-bound paclitaxel 91

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × INDUSTRY × Endoscopic Ultrasound-Guided Fine Needle Aspiration × Clear all
NCT01770405 2017-08-29

US-nCLE

Mauna Kea Technologies

Completed
40 enrolled
Gastrointestinal

Pancreatic adenoma, Lymphadenopathy, Cysts, Adenoma, Islet Cell, Pancreatic Cyst, Pancreatic Neoplasms, Arachnodactyly

Data powered by HemOnc (CC BY 4.0) Colophon âš¡